Why the study?
Do implantable cardioverter-defibrillators prevent sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy?
Do implantable cardioverter-defibrillators prevent sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy?
A single marker of high risk for sudden death may be sufficient to justify prophylactic ICD implantation in selected patients with hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May support ICD consideration in HCM with one risk factor; hypothesis-generating for SCD prevention without RCTs.
In a high-risk HCM cohort, ICD interventions for life-threatening ventricular tachyarrhythmias were frequent and highly effective in restoring normal rhythm. An important proportion of ICD discharges occurred in primary prevention patients who had undergone implantation for a single risk factor. Therefore, a single marker of high risk for sudden death may be sufficient to justify consideration for prophylactic defibrillator implantation in selected patients with HCM.
No takes yet. Share an insight, caveat, or question.
Maron et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: